BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16944703)

  • 1. [Clinical and functional parallels and screening for chronic obstructive lung disease].
    Aripov BS; Tashmetova GT
    Probl Tuberk Bolezn Legk; 2006; (7):5-7. PubMed ID: 16944703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel.
    Stav D; Raz M
    Isr Med Assoc J; 2007 Nov; 9(11):800-2. PubMed ID: 18085037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spirometry for the diagnosis and management of chronic obstructive pulmonary disease.
    Macintyre NR
    Respir Care; 2009 Aug; 54(8):1050-7. PubMed ID: 19650946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
    Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
    COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Office-based spirometry for early detection of obstructive lung disease.
    Wallace LD; Troy KE
    J Am Acad Nurse Pract; 2006 Sep; 18(9):414-21. PubMed ID: 16958772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of chronic obstructive pulmonary disease--secondary publication].
    Hansen JG; Pedersen L; Overvad K; Omland Ø; Jensen HK; Sørensen HT
    Ugeskr Laeger; 2009 Oct; 171(41):2986-8. PubMed ID: 19824224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors that delay COPD detection in the general elderly population.
    Horie J; Murata S; Hayashi S; Murata J; Miyazaki J; Mizota K; Horikawa E
    Respir Care; 2011 Aug; 56(8):1143-50. PubMed ID: 21496370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathomechanisms in chronic obstructive pulmonary disease (COPD)].
    Glaab T; Hohlfeld JM; Jörres RA; Krug N; Welte T
    Med Klin (Munich); 2006 Dec; 101(12):951-6. PubMed ID: 17171318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spirometry screening can identify new cases of asthma and COPD. Public lung function tests at the Stockholm's Central Station].
    Renström A; Merritt AS; Kull I; Hedlin G; Dahlén SE
    Lakartidningen; 2010 Jun; 107(23):1541-4. PubMed ID: 20617776
    [No Abstract]   [Full Text] [Related]  

  • 11. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD.
    Schermer T; Heijdra Y; Zadel S; van den Bemt L; Boonman-de Winter L; Dekhuijzen R; Smeele I
    Respir Med; 2007 Jun; 101(6):1355-62. PubMed ID: 17098407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease.
    Albers M; Schermer T; Heijdra Y; Molema J; Akkermans R; van Weel C
    Thorax; 2008 Mar; 63(3):201-7. PubMed ID: 17905823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farming and the prevalence of non-reversible airways obstruction: results from a population-based study.
    Lamprecht B; Schirnhofer L; Kaiser B; Studnicka M; Buist AS
    Am J Ind Med; 2007 Jun; 50(6):421-6. PubMed ID: 17497693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease.
    Walker PP; Calverley PM
    COPD; 2008 Jun; 5(3):147-52. PubMed ID: 18568838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two points concerning the prevention and management of chronic obstructive pulmonary diseases].
    Zhao M
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Oct; 24(10):577-8. PubMed ID: 11770415
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease in patients admitted with heart failure.
    Iversen KK; Kjaergaard J; Akkan D; Kober L; Torp-Pedersen C; Hassager C; Vestbo J; Kjoller E;
    J Intern Med; 2008 Oct; 264(4):361-9. PubMed ID: 18537871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of SF-36 questionnaire for the measurement of life quality in chronic obstructive pulmonary disease].
    Soyyiğit S; Erk M; Güler N; Kilinç G
    Tuberk Toraks; 2006; 54(3):259-66. PubMed ID: 17001544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of chronic obstructive pulmonary disease on postoperative lung function and complications in patients undergoing operations for primary non-small cell lung cancer.
    Subotic DR; Mandaric DV; Eminovic TM; Gajic MM; Mujovic NM; Atanasijadis ND; Dzeletovic PP; Andric LD; Bulajic BM; Dimitrijevic ID; Sobic DP
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1292-9. PubMed ID: 17976465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.